MedTrace Logo

Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation

NCT02137642 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2016-09-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic motor and sensory effects in patients with chronic constipation.

Conditions

  • Chronic Constipation

Interventions

DRUG

RM-131

Double blind RM-131 (100 ug) will be delivered once by injection during study procedure.

DRUG

Placebo

Double blind placebo will be delivered once by injection during study procedure.

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Motus Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Camilleri, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137642 on ClinicalTrials.gov